bromopyruvate has been researched along with Cancer of Nasopharynx in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Liu, H; Lu, X; Shi, Z; Zhang, P; Zhao, S; Zhu, C | 1 |
| Can, Z; Chenchen, J; Lele, S; Lingling, L; Liu, H; Pei, Z; Qiong, P; Surong, Z; Yiming, S; Yuzhong, C; Zhirui, Z | 1 |
| Jiang, C; Liu, H; Sun, Y; Wei, Y; Zhang, M; Zhang, X; Zhao, S; Zou, X | 1 |
3 other study(ies) available for bromopyruvate and Cancer of Nasopharynx
| Article | Year |
|---|---|
[Down-regulation of miR-205-5p enhances pro-apoptotic effect of 3-bromopyruvate on human nasopharyngeal carcinoma CNE2Z cells].
Topics: Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyruvates | 2019 |
3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyruvates; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Transfection; Up-Regulation | 2017 |
Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyruvates; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2015 |